A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
சென்செக்ஸ்
73,123.83
▼ -0.17%
நிஃப்டி
22,600
▼ -0.39%
தங்கம்
₹ 13,060/gm
வெள்ளி
₹ 2,25,000/kg
பெட்ரோல்
₹ 107.76
டீசல்
₹ 99.55
எல்பிஜி
₹ 957.50
கச்சா எண்ணெய்
$ 114.42
USD
₹ 94.96
சென்செக்ஸ்
73,123.83
▼ -0.17%
நிஃப்டி
22,600
▼ -0.39%
தங்கம்
₹ 13,060/gm
வெள்ளி
₹ 2,25,000/kg
பெட்ரோல்
₹ 107.76
டீசல்
₹ 99.55
எல்பிஜி
₹ 957.50
கச்சா எண்ணெய்
$ 114.42
USD
₹ 94.96
Aditya Birla Sun Life Pharma & Healthcare Fund
Regular
Direct
3 Year Absolute Returns
60.92% ↑
NAV (₹) on 22 Oct 2026
33.60
1 Day NAV Change
0.18%
Risk Level
Very High Risk
Rating
-
Aditya Birla Sun Life Pharma & Healthcare Fund is a Equity mutual fund categorized under Sector, offered by Aditya Birla Sun Life AMC Limited. Launched on 20 Jun 2019, investors can start with a ... Read more
NAV History
Fund Details
Min. SIP Amount
₹100
Inception Date
20 Jun 2019
Min. Lumpsum Amount
₹ 500
Fund Age
7 Yrs
AUM
₹ 1,077.52 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
2.29%
Scheme Type
Open Ended
Exit Load
1%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 1,077.52 Cr
Equity
97.94%
Money Market & Cash
2.92%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 74.44% |
| Hospitals & Medical Services | 20.97% |
| Treps/Reverse Repo | 2.92% |
| Chemicals - Speciality | 1.11% |
| Insurance Distributor | 0.73% |
| Chemicals - Organic - Benzene Based | 0.69% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | 9.28% | ₹ 99.97 | Pharmaceuticals |
| Sun Pharmaceutical Industries Ltd. | 8.61% | ₹ 92.79 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 6.44% | ₹ 69.35 | Hospitals & Medical Services |
| Cipla Ltd. | 6.38% | ₹ 68.71 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 4.52% | ₹ 48.70 | Pharmaceuticals |
| Sai Life Sciences Ltd. | 4.49% | ₹ 48.36 | Pharmaceuticals |
| Ajanta Pharma Ltd. | 4.35% | ₹ 46.82 | Pharmaceuticals |
| Mankind Pharma Ltd. | 3.62% | ₹ 38.95 | Pharmaceuticals |
| Dr. Lal Path labs Ltd. | 3.51% | ₹ 37.77 | Hospitals & Medical Services |
| Abbott India Ltd. | 3.26% | ₹ 35.08 | Pharmaceuticals |
| Emcure Pharmaceuticals Ltd. | 3.21% | ₹ 34.54 | Pharmaceuticals |
| Lupin Ltd. | 2.94% | ₹ 31.71 | Pharmaceuticals |
| TREPS | 2.92% | ₹ 31.41 | Others |
| IPCA Laboratories Ltd. | 2.71% | ₹ 29.20 | Pharmaceuticals |
| Gland Pharma Ltd. | 2.70% | ₹ 29.14 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 2.42% | ₹ 26.10 | Hospitals & Medical Services |
| Corona Remedies Ltd. | 2.27% | ₹ 24.49 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 2.24% | ₹ 24.16 | Pharmaceuticals |
| Procter & Gamble Health Ltd. | 1.82% | ₹ 19.58 | Pharmaceuticals |
| Thyrocare Technologies Ltd. | 1.76% | ₹ 18.94 | Hospitals & Medical Services |
| Alkem Laboratories Ltd. | 1.68% | ₹ 18.09 | Pharmaceuticals |
| Jupiter Life Line Hospitals Ltd. | 1.55% | ₹ 16.66 | Hospitals & Medical Services |
| Metropolis Healthcare Ltd. | 1.48% | ₹ 15.91 | Hospitals & Medical Services |
| Biocon Ltd. | 1.45% | ₹ 15.63 | Pharmaceuticals |
| Shilpa Medicare Ltd. | 1.43% | ₹ 15.39 | Pharmaceuticals |
| Piramal Pharma Ltd. | 1.22% | ₹ 13.18 | Pharmaceuticals |
| Dr. Reddy's Laboratories Ltd. | 1.13% | ₹ 12.20 | Pharmaceuticals |
| Anthem Biosciences Ltd. | 1.13% | ₹ 12.16 | Pharmaceuticals |
| Sanofi Consumer Healthcare India Ltd. | 1.11% | ₹ 12 | Chemicals - Speciality |
| Suraksha Diagnostic Ltd. | 1.10% | ₹ 11.90 | Hospitals & Medical Services |
| Manipal Health Enterprises Ltd | 1.07% | ₹ 11.50 | Hospitals & Medical Services |
| Vijaya Diagnostic Centre Ltd. | 1.04% | ₹ 11.24 | Hospitals & Medical Services |
| Pfizer Ltd. | 1.01% | ₹ 10.87 | Pharmaceuticals |
| Natco Pharma Ltd. | 0.92% | ₹ 9.93 | Pharmaceuticals |
| Glaxosmithkline Pharmaceuticals Ltd. | 0.83% | ₹ 8.97 | Pharmaceuticals |
| Medi Assist Healthcare Services Ltd. | 0.73% | ₹ 7.90 | Insurance Distributor |
| Vinati Organics Ltd. | 0.69% | ₹ 7.47 | Chemicals - Organic - Benzene Based |
| Syngene International Ltd. | 0.64% | ₹ 6.91 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 0.60% | ₹ 6.51 | Hospitals & Medical Services |
| Jubilant Pharmova Ltd. | 0.60% | ₹ 6.49 | Pharmaceuticals |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 12.60% | 7.04% | 3.39% | 17.18% |
| Category returns | 1.88% | -1.84% | 2.14% | 17.66% |
Fund Objective
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
AMC Details
Name
Aditya Birla Sun Life AMC Limited
Date of Incorporation
23 Dec 1994
CEO
Mr. A Balasubramanian
CIO
Type
Pvt.Sector-Joint Venture (Indian)
Address
One World Center, Tower 1, 17th Floor,
Jupiter Mills,
Senapati Bapat Marg,
Elphinstone Road, Mumbai, Maharashtra, India - 400013
Website
https://mutualfund.adityabirlacapital.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹33.24 | 90.88% | 281.41% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹33.24 | 90.88% | 281.41% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹33.24 | 90.88% | 281.41% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹30.99 | 88.34% | 266.02% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹30.99 | 88.34% | 266.02% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹30.99 | 88.34% | 266.02% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.03 | 14.09% | 137.11% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.03 | 14.09% | 137.11% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.03 | 14.09% | 137.11% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹27.97 | 13.00% | 129.56% | 0.00% | ₹11,493 | 1.79% |
Very High
|
Top Funds from Aditya Birla Sun Life AMC Limited
FAQs
What is the current NAV of Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth?
The current Net Asset Value (NAV) of Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is ₹33.60 as of 22 Oct 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth?
The Assets Under Management (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is ₹1,077.52 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth?
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth has delivered returns of 7.04% (1 Year), 17.18% (3 Year), 11.98% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth?
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth?
The minimum lumpsum investment required for Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is ₹500. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹100, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+